Swiss Emmaus Leprosy Relief Work India

What Swiss Emmaus Leprosy Relief Work India does

Swiss Emmaus Leprosy Relief Work India (SEI), also known as FAIRMED India, is a nonprofit organization headquartered in Gurgaon, Haryana, with operations across four Indian states (Andhra Pradesh, Karnataka, Tamil Nadu, Maharashtra) and an active expansion into Chhattisgarh via the 2023–2026 Aagaaz project. Founded in 1956 with India operations beginning in 1960, SEI functions as the Indian country program of Swiss parent FAIRMED Bern. The organization's core technology stack comprises two proprietary digital systems: a centralized Hospital Information System (HIS) that captures patient data from five government-recognized tertiary care hospitals, and a Tablet Information System (TIS) — copyright-registered in 2017 — that captures field-based program data and feeds it into central systems. Together, these tools won the Young Scientist Award at the International Leprosy Congress in Brussels in 2013.

The organization's service portfolio spans tertiary leprosy care (reconstructive surgery, ulcer care, reaction management), Prevention of Impairment and Disability (POID) community projects in Andhra Pradesh and Maharashtra, MCR footwear manufacturing, children's education at three hospital-affiliated schools (serving ~1,500 children), and health awareness campaigns reaching over 32 lakh people annually via schools, colleges, and bulk-SMS outreach. Distribution is executed through a hybrid model of partner NGOs (RISDT, GRETNALTES, Hubli Hospital for the Handicapped, Sacred Heart Leprosy Center), mobile action teams covering 110 PHCs per district, ASHA worker networks, and direct integration with the Government's NLEP at central and state levels.

Revenue mechanics are donation- and grant-driven rather than commercial. SEI is FCRA-registered (enabling foreign contributions), CSR-registered (enabling corporate CSR funding from ONGC, BPCL, and Novartis), and holds 80G/12A tax-exemption status. The organization publishes unit sponsorship costs (e.g., MCR footwear at Rs. 480/pair, foot reconstruction at Rs. 34,830) that donors can fund directly, alongside periodic contribution tiers starting at Rs. 500. Individual donors, corporate CSR partners, and FAIRMED Bern provide the funding base. No revenue figures are disclosed publicly; no equity funding rounds, M&A activity, or subsidiaries exist.

Name

Swiss Emmaus Leprosy Relief Work India

Legal name

Swiss Emmaus Leprosy Relief Work India

Website

https://swissemmausindia.org

Company type

Private

Founded year

1957

Operating status

Operating

Headcount range

51–100 employees

Short description

Swiss Emmaus Leprosy Relief Work India is a Gurgaon-based nonprofit that delivers medical and social rehabilitation services to people affected by leprosy across four to five Indian states, supporting five tertiary care hospitals and community-based prevention programs funded through donations, CSR, and parent FAIRMED Bern.

Ownership category

akta.pro rank

Product category

Leprosy Care and Rehabilitation Services

NAICS

Voluntary Health Organizations (813212), Social Assistance (624)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro industry

PRIMARYHLAJAKAF

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

SECONDARYBPADAEAH

Health Systems Strengthening & Global Health Technical Assistance

Business & Public Services/International Organizations & Development/International Development & Technical Assistance

SECONDARYHLAJAOAE

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

Keywords

• Leprosy treatment services
• Community health programs
• Disability prevention care
• Medical rehabilitation services
• Public health initiatives

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Contributions: Individual donors, corporate partners, and global supporters make monetary contributions to support SEI's programs. SEI is FCRA registered (075900321) enabling receipt of foreign contributions and CSR registered (CSR00003001). Minimum contribution amount is Rs. 500. One-time and periodic contribution options available.
2. Corporate Partnerships: ONGC, BPCL, and Novartis provide corporate volunteering and financial support through CSR activities. These partnerships help amplify efforts in creating sustainable impact on communities.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Core offering

Swiss Emmaus Leprosy Relief Work India provides free medical treatment, reconstructive surgery, ulcer care, and social rehabilitation to people affected by leprosy across India through a network of 5 government-recognized tertiary hospitals and community-based POID projects. The organization also manufactures specialized MCR protective footwear, runs children's education programs at hospital-attached schools, conducts public health awareness campaigns reaching over 32 lakh people annually, and facilitates access to government welfare schemes for affected persons.

Product overview

Swiss Emmaus Leprosy Relief Work India (SEI/FAIRMED India) is a non-profit organization providing a comprehensive leprosy care ecosystem rather than a single product. The core technology products include the Hospital Information System (HIS) — a centralized monitoring platform for tertiary hospital patient data — and the Tablet Information System (TIS) — a handheld field data collection system. These are complemented by direct healthcare services: tertiary leprosy care across 5 government-recognized hospitals, Prevention of Impairment and Disability (POID) community-based projects, health awareness programs, in-patient and out-patient treatment services, MCR protective footwear, children's education support, and government scheme facilitation. The organization also publishes research documents including leprosy FAQs and migration studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Tertiary Leprosy Care Services
• Prevention of Impairment and Disability (POID) Projects
• In-Patient Treatment Services

Quantifiable outcome

• POID project services approximately 6,500 affected persons across East Godavari & Guntur districts in Andhra Pradesh
• +4 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

15 partnerships are on record, tiered core, major and minor.

• FAIRMED Berne (Switzerland)coreStrategic or Co-development Partner · 1 January 1959FAIRMED Berne (Headquarters) is the parent organization of Swiss Emmaus Leprosy Relief Work India. SEI was originally founded as part of the Emmaus movement and later rebranded as FAIRMED India in 2009-2010. HQ provides strategic direction, funding support, and program guidance for FM India country program.
• Rural India Self Development Trust (RISDT)coreStrategic or Co-development PartnerRISDT established at Rajahmundry in 1985, operating Leprosy Control Unit (LCU) in Kathipudi providing tertiary care services: reconstructive surgery, ulcer care, reaction management, physiotherapy, and MCR footwear unit. 60-bedded THW ward. Installed Multi-specialty Operation Theatre Complex in 2018.
• GRETNALTES (Greater Tenali Leprosy Treatment and Education Scheme)coreStrategic or Co-development PartnerGRETNALTES established in 1981 in Tenali, covering population of 3.5 million, detected and treated 65,000 new cases of leprosy. Services include clinical leprosy treatment, reconstructive surgeries, general health services, MCR footwear manufacturing, TB treatment, and free education for unprivileged children.
• Hubli Hospital for the Handicapped (HHH)coreStrategic or Co-development PartnerHHH established in 1976 in Karnataka, providing comprehensive leprosy services including population survey, reconstructive surgery, and vocational rehabilitation. Has detected and cured 20,255 cases of leprosy. Contributed to reducing leprosy rate from 17 to 0.69 per 10,000 population.
• Sacred Heart Leprosy Center (SHLC)coreStrategic or Co-development PartnerSHLC is a referral center founded in 1916, providing leprosy investigation and treatment through Out-Patient Department. Started unique Middle School in 1948 for educating leprosy-affected children and children of affected parents. Completed Diamond Jubilee (1976) and Platinum (1991).
• ILEP (International Federation of Anti-Leprosy Associations)coreStrategic or Co-development PartnerSEI is a member of ILEP India (formed in collaboration with other ILEP members in 1992). FM India's National Program Manager serves as ILEP consultant. SEI also served as ILEP India Coordinator in 2017.
• Central Leprosy Division (CLD), Ministry of Health & Family Welfare, Government of IndiacoreStrategic or Co-development PartnerCLD is the national nodal agency for leprosy control. SEI collaborates with CLD for leprosy programs, participated in discussions for country program strategy 2021-2024, and works on pilot projects like leprosy and migration study.
• WHO IndiacoreStrategic or Co-development PartnerWHO India collaborates with SEI on leprosy and migration study. WHO officers work with SEI and ILEP agencies for project implementation in high-burden areas like Chhattisgarh.
• Association of People Affected by Leprosy (APAL)coreStrategic or Co-development PartnerAPAL is a people's forum for leprosy-affected individuals. Collaborates with SEI on leprosy and migration pilot study, ILEP India coordination, and ensuring disability and gender inclusion in projects.
• ALERT IndiamajorStrategic or Co-development PartnerALERT India partnered with SEI for the MH-POID (Maharashtra - Prevention of Impairment and Disability) project in Dhule and Jalgaon districts. Also involved in capacity building and contextualizing NLEP training modules.
• ONGC (Oil and Natural Gas Corporation Limited)majorGTM or Marketing PartnerONGC is a corporate partner providing CSR support to SEI's programs. Corporate volunteering helps amplify efforts of SEI's network of volunteers and hospital partners.
• BPCL (Bharat Petroleum Corporation Limited)majorGTM or Marketing PartnerBPCL is a corporate partner providing CSR support to SEI's community programs. Partnership creates sustainable impact on supported communities.
• The Leprosy Mission (TLM) IndiamajorStrategic or Co-development PartnerTLM India is an ILEP member. SEI utilizes TLM's hospitals in Jangir Champa and Mungeli (Chhattisgarh) for advanced leprosy care, complementing primary and secondary healthcare services under Aagaaz project.
• ChangeScape ConsultingminorStrategic or Co-development PartnerChangeScape Consulting collaborated with SEI on the leprosy and migration study in India, including development of 'Musafir' film documenting migration and leprosy challenges.
• Steel Authority of India (SAIL)minorStrategic or Co-development PartnerSAIL is being engaged as a local partner in Durg district of Chhattisgarh for Aagaaz project, contributing to health system strengthening initiatives.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• The Leprosy Mission Trust India: The Leprosy Mission Trust India is one of India's largest leprosy-focused NGOs, operating hospitals, community programs, and advocacy in alignment with NLEP. It is both an ILEP collaborator and a direct comparator in tertiary leprosy care, reconstructive surgery, and community rehabilitation, serving the same affected populations as SEI.
• ALERT India: ALERT India is a leprosy and NTD-focused NGO delivering community-based prevention of impairment and disability (POID) programs and NLEP training, including as a direct partner with SEI on the Maharashtra POID project. Overlap in target population, geography, and POID methodology makes it a directly comparable peer.
• Damien Foundation India Trust: Damien Foundation India Trust runs leprosy control programs, tertiary care, and TB services across multiple Indian states, often in collaboration with government health systems. Its mission, target population, and ILEP-aligned operating model closely mirror SEI's leprosy and poverty-related disease focus.
• NLR India (No Leprosy Remains): NLR India, formerly Netherlands Leprosy Relief, is an international NGO working to stop leprosy transmission and prevent disability across Indian states. It shares SEI's disease-specific focus, government partnership approach, and ILEP-aligned methodology, making it a direct comparator.
• LEPRA Society: LEPRA Society is a long-standing leprosy NGO working in India on case detection, disability prevention, and community rehabilitation, with overlapping ILEP membership. It addresses the same affected populations and uses comparable POID-style community health worker models.
• Sasakawa Health Foundation / Sasakawa-India Leprosy Foundation: Sasakawa Health Foundation supports leprosy elimination, disability prevention, and stigma reduction globally, with active programs in India. Its disease-specific NTD focus, government partnership approach, and advocacy role are comparable to SEI's mandate and activities.
• FAIRMED (Bern): FAIRMED Bern is SEI's parent organization and runs parallel leprosy and NTD programs in other African and Asian countries. As the same network, it shares mission, methodology, and donor base, and serves as a useful benchmark for SEI's strategic direction and scaling potential.

Broad incumbents

• World Health Organization (WHO) India: WHO India sets normative guidance and convenes partners for NTD/leprosy elimination in India and collaborates with SEI on research projects. While not a service-delivery peer, it is the broader incumbent shaping the policy and funding landscape in which SEI operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/swissemmaus
• Facebookfacebook.com/SwissEmmausIN
• LinkedInlinkedin.com/company/swiss-emmaus-leprosy-relief-work-india

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Swiss Emmaus Leprosy Relief Work India